Julie Hastin
Medical · Oceanside, CANPI 1962787838
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 170 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,132, more than ten times the $45 reported in 2021.
Across 170 payments — averaging $20.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$682
- Amgen$485
- Johnson & Johnson$419
- Novartis$392
- UCB, Inc.$376
- AstraZeneca$268
- plus $916 from 17 others
What the payments were for
- Food & beverage$3,48398%
- Education$552%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 33 | $682 |
| Amgen | 36 | $485 |
| Johnson & Johnson | 25 | $419 |
| Novartis | 16 | $392 |
| UCB, Inc. | 12 | $376 |
| AstraZeneca(2 entities) | 10 | $268 |
| GSK | 9 | $240 |
| Lilly USA, LLC | 8 | $163 |
| Boehringer Ingelheim | 5 | $138 |
| Kyowa Kirin, Inc. | 2 | $53 |
| Sobi, Inc | 1 | $39 |
| Genentech USA, Inc. | 2 | $35 |
| Mallinckrodt Hospital Products Inc. | 1 | $35 |
| Almatica Pharma LLC | 1 | $29 |
| Aurinia Pharma U.S., Inc. | 1 | $29 |
| Sanofi | 1 | $28 |
| Radius Health, Inc. | 1 | $25 |
| Alvogen Inc | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
| Tonix Medicines, Inc. | 1 | $18 |
| Pfizer | 1 | $18 |
| Avanos Medical | 1 | $15 |
| Organon | 1 | $7 |
How this compares
$3,538 in reported general payments places this provider in the 80th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 14 | $134,928 |
| Enbrel SureclickEtanercept | 12 | $92,309 |
| Orencia ClickjectAbatacept | 13 | $69,020 |
| Hydroxychloroquine Sulfate | 92 | $4,733 |
| MethotrexateMethotrexate Sodium | 114 | $4,360 |
| Pilocarpine Hcl | 15 | $2,153 |
| Leflunomide | 22 | $1,438 |
| Leucovorin Calcium | 12 | $1,318 |
| Gabapentin | 21 | $805 |
| Duloxetine Hcl | 55 | $769 |
| Folic Acid | 47 | $586 |
| Prednisone | 74 | $540 |
| Methylprednisolone | 13 | $192 |
| Allopurinol | 11 | $187 |
Paid to pharmacies, not to this prescriber.
Other medical in Oceanside
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- David DoriguzziLancaster$166K
- Deirdre MoxleyFullerton$149K
- Linda RankLadera Ranch$105K
- Cheryl KyinnSan Diego$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.